Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics Market Cap : 518.84M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 518.84M |
| November 19, 2026 | 527.89M |
| November 18, 2026 | 527.89M |
| November 17, 2026 | 509.79M |
| November 16, 2026 | 543.72M |
| November 13, 2026 | 591.23M |
| November 12, 2026 | 603.30M |
| November 11, 2026 | 654.58M |
| November 10, 2026 | 625.92M |
| November 09, 2026 | 639.50M |
| November 06, 2026 | 588.22M |
| November 05, 2026 | 544.48M |
| November 04, 2026 | 555.04M |
| November 03, 2026 | 564.09M |
| November 02, 2026 | 531.33M |
| October 30, 2026 | 555.10M |
| October 29, 2026 | 557.90M |
| October 28, 2026 | 553.70M |
| October 27, 2026 | 529.93M |
| October 26, 2026 | 529.93M |
| October 23, 2026 | 524.34M |
| October 22, 2026 | 535.53M |
| October 21, 2026 | 532.73M |
| October 20, 2026 | 527.14M |
| October 19, 2026 | 486.59M |
| Date | Value |
|---|---|
| October 16, 2026 | 458.62M |
| October 15, 2026 | 487.99M |
| October 14, 2026 | 472.61M |
| October 13, 2026 | 485.19M |
| October 12, 2026 | 503.37M |
| October 09, 2026 | 535.53M |
| October 08, 2026 | 529.93M |
| October 07, 2026 | 475.40M |
| October 06, 2026 | 517.35M |
| October 05, 2026 | 597.05M |
| October 02, 2026 | 613.83M |
| October 01, 2026 | 616.63M |
| September 30, 2026 | 735.48M |
| September 29, 2026 | 738.27M |
| September 28, 2026 | 759.25M |
| September 25, 2026 | 720.10M |
| September 24, 2026 | 752.25M |
| September 23, 2026 | 735.48M |
| September 22, 2026 | 799.80M |
| September 21, 2026 | 778.82M |
| September 18, 2026 | 769.03M |
| September 17, 2026 | 755.05M |
| September 16, 2026 | 743.87M |
| September 15, 2026 | 772.53M |
| September 14, 2026 | 788.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.570B |
| Corcept Therapeutics, Inc. | 6.958B |
| Veru, Inc. | 33.08M |
| Johnson & Johnson | 651.05B |
| Eli Lilly & Co. | 1.268T |
Market Cap Related Metrics
| PS Ratio | 73.04 |
| Price to Book Value | 3.111 |
| Price | 3.44 |
| Earnings Yield | -17.15% |